324 related articles for article (PubMed ID: 29893860)
1. Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis?
Guo SW; Groothuis PG
Hum Reprod Update; 2018 Sep; 24(5):577-598. PubMed ID: 29893860
[TBL] [Abstract][Full Text] [Related]
2. Various types of adenomyosis and endometriosis: in search of optimal management.
Guo SW
Fertil Steril; 2023 May; 119(5):711-726. PubMed ID: 36963717
[TBL] [Abstract][Full Text] [Related]
3. Drug Development in Endometriosis and Adenomyosis: It Takes More Than Just Good Science.
Groothuis PG; Guo SW
Reprod Sci; 2018 Sep; 25(9):1318-1329. PubMed ID: 29962279
[TBL] [Abstract][Full Text] [Related]
4. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis.
Benagiano G; Brosens I; Habiba M
Hum Reprod Update; 2014; 20(3):386-402. PubMed ID: 24140719
[TBL] [Abstract][Full Text] [Related]
5. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
Liu X; Shen M; Qi Q; Zhang H; Guo SW
Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
[TBL] [Abstract][Full Text] [Related]
6. An overview of the current status of clinical trials on endometriosis: issues and concerns.
Guo SW
Fertil Steril; 2014 Jan; 101(1):183-190.e4. PubMed ID: 24112527
[TBL] [Abstract][Full Text] [Related]
7. Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review.
Harmsen MJ; Wong CFC; Mijatovic V; Griffioen AW; Groenman F; Hehenkamp WJK; Huirne JAF
Hum Reprod Update; 2019 Sep; 25(5):647-671. PubMed ID: 31504506
[TBL] [Abstract][Full Text] [Related]
8. Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies.
Meresman GF; Götte M; Laschke MW
Hum Reprod Update; 2021 Feb; 27(2):367-392. PubMed ID: 33124671
[TBL] [Abstract][Full Text] [Related]
9. Lack of transparency of clinical trials on endometriosis.
Guo SW; Evers JLH
Obstet Gynecol; 2013 Jun; 121(6):1281-1290. PubMed ID: 23812463
[TBL] [Abstract][Full Text] [Related]
10. Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis.
Chen YJ; Li HY; Huang CH; Twu NF; Yen MS; Wang PH; Chou TY; Liu YN; Chao KC; Yang MH
J Pathol; 2010 Nov; 222(3):261-70. PubMed ID: 20814901
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
12. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
Adis International Ltd
Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
[TBL] [Abstract][Full Text] [Related]
13. Kinase signalling pathways in endometriosis: potential targets for non-hormonal therapeutics.
McKinnon BD; Kocbek V; Nirgianakis K; Bersinger NA; Mueller MD
Hum Reprod Update; 2016 Apr; 22(3):382-403. PubMed ID: 26740585
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes.
Chapron C; Tosti C; Marcellin L; Bourdon M; Lafay-Pillet MC; Millischer AE; Streuli I; Borghese B; Petraglia F; Santulli P
Hum Reprod; 2017 Jul; 32(7):1393-1401. PubMed ID: 28510724
[TBL] [Abstract][Full Text] [Related]
15. New ways of insulin delivery.
Heinemann L
Int J Clin Pract Suppl; 2011 Feb; (170):31-46. PubMed ID: 21323811
[TBL] [Abstract][Full Text] [Related]
16. A peek into the drug development scenario of endometriosis - A systematic review.
Goenka L; George M; Sen M
Biomed Pharmacother; 2017 Jun; 90():575-585. PubMed ID: 28407578
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoids modulate apoptosis in endometriosis and adenomyosis.
Bilgic E; Guzel E; Kose S; Aydin MC; Karaismailoglu E; Akar I; Usubutun A; Korkusuz P
Acta Histochem; 2017 Jun; 119(5):523-532. PubMed ID: 28549792
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for endometriosis.
Fedele L; Berlanda N
Expert Opin Emerg Drugs; 2004 May; 9(1):167-77. PubMed ID: 15155142
[TBL] [Abstract][Full Text] [Related]
19. Hormonal treatments for adenomyosis.
Fedele L; Bianchi S; Frontino G
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):333-9. PubMed ID: 17765017
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for endometriosis.
Guo SW
Expert Opin Emerg Drugs; 2008 Dec; 13(4):547-71. PubMed ID: 19046127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
